Computerized Assessment of Psychosis Risk
- PMID: 34307899
- PMCID: PMC8302046
- DOI: 10.20900/jpbs.20210011
Computerized Assessment of Psychosis Risk
Abstract
Early detection and intervention with young people at clinical high risk (CHR) for psychosis is critical for prevention efforts focused on altering the trajectory of psychosis. Early CHR research largely focused on validating clinical interviews for detecting at-risk individuals; however, this approach has limitations related to: (1) specificity (i.e., only 20% of CHR individuals convert to psychosis) and (2) the expertise and training needed to administer these interviews is limited. The purpose of our study is to develop the computerized assessment of psychosis risk (CAPR) battery, consisting of behavioral tasks that require minimal training to administer, can be administered online, and are tied to the neurobiological systems and computational mechanisms implicated in psychosis. The aims of our study are as follows: (1A) to develop a psychosis-risk calculator through the application of machine learning (ML) methods to the measures from the CAPR battery, (1B) evaluate group differences on the risk calculator score and test the hypothesis that the risk calculator score of the CHR group will differ from help-seeking and healthy controls, (1C) evaluate how baseline CAPR battery performance relates to symptomatic outcome two years later (i.e., conversion and symptomatic worsening). These aims will be explored in 500 CHR participants, 500 help-seeking individuals, and 500 healthy controls across the study sites. This project will provide a next-generation CHR battery, tied to illness mechanisms and powered by cutting-edge computational methods that can be used to facilitate the earliest possible detection of psychosis risk.
Keywords: behavioral tasks; clinical high-risk; computational psychiatry; computerized assessment; precision medicine; prodrome; psychosis; risk calculator; risk screening; schizophrenia.
Conflict of interest statement
CONFLICTS OF INTEREST The authors report no conflicts of interest.
Figures
References
-
- Brown S Excess mortality of schizophrenia: a meta-analysis. Br J Psychiatry. 1997;171(6):502–8. - PubMed
-
- Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS. Premature Mortality Among Adults With Schizophrenia in the United States. JAMA Psychiatry. 2015. December 1;72(12):1172. - PubMed
-
- Ho B-C, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry. 1998;155(9):1196–201. - PubMed
-
- Penttilä M, Jääskeläinen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2014;205(2):88–94. - PubMed
-
- Ran M-S, Xiao Y, Chui CH, Hu X-Z, Yu Y-H, Peng M-M, et al. Duration of untreated psychosis (DUP) and outcome of people with schizophrenia in rural China: 14-year follow-up study. Psychiatry Res. 2018;267:340–5. - PubMed
Grants and funding
- R01 MH112613/MH/NIMH NIH HHS/United States
- R01 MH112612/MH/NIMH NIH HHS/United States
- UL1 TR001863/TR/NCATS NIH HHS/United States
- R01 MH120089/MH/NIMH NIH HHS/United States
- K23 MH115252/MH/NIMH NIH HHS/United States
- R01 MH120090/MH/NIMH NIH HHS/United States
- R01 MH112545/MH/NIMH NIH HHS/United States
- R01 MH116039/MH/NIMH NIH HHS/United States
- R21 MH119438/MH/NIMH NIH HHS/United States
- R01 MH120091/MH/NIMH NIH HHS/United States
- R01 MH120088/MH/NIMH NIH HHS/United States
- R01 MH120092/MH/NIMH NIH HHS/United States
- U01 MH081988/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Miscellaneous